接种PrPSc特异性疫苗并暴露于朊病毒污染环境的麋鹿慢性消耗病发病加速
本研究在朊病毒污染环境中自然暴露的麋鹿中评估一种针对YYR表位的CWD疫苗。41头雌性麋鹿幼崽被随机分为疫苗组(n=21)和对照组(n=20)。疫苗诱导了YYR特异性抗体,但132MM基因型接种麋鹿的平均生存期(800天)显著短于未接种同基因型麋鹿(1062天,p=0.003),且RAMALT活检阳性时间更早。
要点
- 接种PrPSc特异性疫苗可诱导YYR特异性抗体,但132MM基因型麋鹿生存期反而缩短。
- 132MM接种组平均生存800天,未接种组1062天(p=0.003)。
- 132MM接种组RAMALT活检阳性时间显著早于未接种组(p=0.012)。
核心结论
- 在朊病毒污染环境中,接种PrPSc特异性疫苗加速了132MM基因型麋鹿的CWD发病,表现为生存期缩短和RAMALT活检阳性时间提前。
- 132ML基因型接种与对照组在生存期和RAMALT活检阳性时间上无显著差异。
- YYR特异性抗体滴度与生存时间无强相关性(p=0.17)。
研究设计与样本
- 研究纳入41头雌性麋鹿幼崽,捕获自怀俄明州西部,置于自1979年记录有CWD的Thorne-Williams野生动物研究中心污染围栏中14至20天。
- 麋鹿交替分配至疫苗组(n=21)或对照组(n=20)。
- 接种组初始间隔约42天接种两次,之后每年接种。
- 通过每日观察临床体征、定期直肠肛管黏膜相关淋巴组织(RAMALT)活检和血清YYR特异性抗体滴度监测进行随访。
- 对朊蛋白基因第132位密码子进行基因分型。
主要发现
- 接种诱导所有动物YYR特异性抗体滴度升高。
- 132MM基因型接种麋鹿(n=15)平均生存期800天,显著短于未接种同基因型麋鹿(n=13)的1062天(p=0.003)。
- 132MM接种麋鹿RAMALT活检阳性平均天数显著短于未接种132MM麋鹿(p=0.012)。
- 132ML基因型接种组(n=4)与对照组(n=5)生存期无显著差异(p=0.35),RAMALT活检阳性时间也无显著差异(p=0.66)。
- YYR特异性抗体滴度与生存时间无强相关性(p=0.17)。
关键数值与推荐
- 132MM基因型接种组平均生存期800天,未接种组1062天(p=0.003)。
- 132MM基因型接种组RAMALT活检阳性平均天数显著短于未接种组(p=0.012)。
- 132ML基因型接种组与对照组生存期比较p=0.35,RAMALT活检阳性时间比较p=0.66。
- YYR特异性抗体滴度与生存时间相关性p=0.17。
临床怎么用
- 该疫苗在132MM基因型麋鹿中加速CWD发病,不支持在当前形式下用于CWD防控。
- 需进一步研究疫苗加速发病的机制以指导未来CWD疫苗研发。
- 在评估CWD疫苗时需考虑宿主基因型对疫苗效果的潜在影响。
局限性
- 研究样本量有限,尤其132ML基因型亚组样本较小。
- 研究在圈养污染环境中进行,结果外推至自由放养种群需谨慎。
- 未阐明疫苗加速发病的具体机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic wasting disease (CWD) is a fatal prion disease affecting multiple cervid species. Effective management tools for this disease, particularly in free-ranging populations, are currently limited. We evaluated a novel CWD vaccine in elk (Cervus canadensis) naturally exposed to CWD through a prion-contaminated environment. The vaccine targets a YYR disease-specific epitope to induce antibody responses specific to the misfolded (PrPSc) conformation. Female elk calves (n = 41) were captured from western Wyoming and transported to the Thorne-Williams Wildlife Research Center where CWD has been documented since 1979. Elk were held in contaminated pens for 14 to 20 days before being alternately assigned to either a vaccine (n = 21) or control group (n = 20). Vaccinated animals initially received two vaccinations approximately 42 days apart and annual vaccinations thereafter. Vaccination induced elevated YYR-specific antibody titers in all animals. Elk were genotyped for the prion protein gene at codon 132, monitored for clinical signs of CWD through daily observation, for disease status through periodic biopsy of rrectoanal mucosa-associated lympoid tissue (RAMALT), and monitored for YYR-specific serum antibody titres. Mean survival of vaccinated elk with the 132MM genotype (n = 15) was significantly shorter (800 days) than unvaccinated elk (n = 13) of the same genotype (1062 days; p = 0.003). Mean days until positive RAMALT biopsy for 132MM vaccinated elk (6 7 8) were significantly shorter than unvaccinated 132MM elk (990; p = 0.012). There was, however, no significant difference in survival between vaccinated (n = 4) and control (n = 5) elk with the 132ML genotype (p = 0.35) or in timing of positive RAMALT biopsies of 132ML elk (p = 0.66). There was no strong (p = 0.17) correlation between YYR-specific antibody titers and survival time. Determining the mechanism by which this vaccine accelerates onset of CWD will be important to direct further CWD vaccine research.
引用
- Wood ME, Griebel P, Huizenga ML, et al. Accelerated onset of chronic wasting disease in elk (Cervus canadensis) vaccinated with a PrPSc-specific vaccine and housed in a prion contaminated environment. Vaccine. 2018. PMID: 30414779. doi:10.1016/j.vaccine.2018.10.057
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。